+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis



Prognostic factors of postrecurrence survival in completely resected stage I non-small cell lung cancer with distant metastasis



Thorax 65(3): 241-245



Distant metastasis after surgical resection is the most frequent cause of death in patients with non-small cell lung cancer (NSCLC). This study aimed to investigate the patterns of distant metastasis and the prognostic factors of postrecurrence survival in patients with resected stage I NSCLC with distant metastases. The clinicopathological characteristics of 166 patients with distant metastases after complete resection of stage I NSCLC at Taipei Veterans General Hospital between 1980 and 2000 were retrospectively reviewed. The patients were divided into two groups according to patterns of distant metastasis (single or multiple organ metastases). Predictors of postrecurrence survival were analysed. The patterns of distant metastasis included single organ metastasis in 106 (63.9%) and multiple organ metastases in 60 (36.1%) patients. The 1- and 2-year postrecurrence survival rates for those with single organ metastasis were 30.2% and 15.1%, respectively. The most common site of single organ metastasis was bone (32.1%), followed by the brain (29.2%). Multivariate analysis revealed that disease-free interval >16 months (HR 0.534; 95% CI 0.288 to 0.990; p=0.046) and treatment for distant metastasis (including re-operation, chemotherapy and/or radiotherapy) (HR 0.245; 95% CI 0.089 to 0.673; p=0.006) were significant predictors of better postrecurrence survival in resected stage I NSCLC with single organ metastasis. A longer disease-free interval is a favourable prognostic predictor for postrecurrence survival in resected stage I NSCLC with single organ metastasis. Treatment for distant metastasis significantly prolongs postrecurrence survival.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 055210502

Download citation: RISBibTeXText

PMID: 20335294

DOI: 10.1136/thx.2008.110825


Related references

P1.08-066 Prognostic Factors of Post-Recurrence Survival in Patients with Completely Resected Stage Iii-N2 Non-Small Cell Lung Cancer. Journal of Thoracic Oncology 12(1): S771-S772, 2017

Prognostic factors for post-recurrence survival in patients with completely resected Stage III (N2) non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 54(3): 554-559, 2018

Prognostic factors for post-recurrence survival in patients with completely resected Stage I non-small-cell lung cancer. European Journal of Cardio-Thoracic Surgery 45(2): 262-267, 2014

Predictors of death, local recurrence, and distant metastasis in completely resected pathological stage-I non-small-cell lung cancer. Journal of Thoracic Oncology 7(7): 1115-1123, 2012

Biological prognostic factors for early stage completely resected non-small cell lung cancer. Journal of Surgical Oncology 74(1): 53-60, 2000

Prognostic factors and the significance of treatment after recurrence in completely resected stage I non-small cell lung cancer. Chest 143(6): 1626-1634, 2013

Predicting postrecurrence survival among completely resected nonsmall-cell lung cancer patients. Annals of Thoracic Surgery 81(3): 1021-1027, 2006

Completely resected n0 non-small cell lung cancer: prognostic factors affecting long-term survival. Isrn Surgery 2013: 175304, 2013

Prognostic factors in 3315 completely resected cases of clinical stage I non-small cell lung cancer in Japan. Journal of Thoracic Oncology 2(5): 408-413, 2007

Distant Metastasis and Survival Outcomes after Computed Tomography-Guided Needle Biopsy in Resected Stage I-III Non-Small Cell Lung Cancer. Journal of Cancer 8(16): 3356-3361, 2017

Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clinical Cancer Research 4(1): 241-249, 1998

Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage. Journal of Thoracic and Cardiovascular Surgery 110(3): 601-605, 1995

Prognostic Factors for Post Recurrence Survival in Resected Pathological Stage I Non-small Cell Lung Cancer. Yonago Acta Medica 60(4): 213-219, 2017

Time trends of overall survival and survival after recurrence in completely resected stage I non-small cell lung cancer. Journal of Thoracic Oncology 7(2): 397-405, 2012

Fas expression in non-small cell lung cancer: its prognostic effect in completely resected stage III patients. European Journal of Cancer 35(10): 1462-1465, 1999